These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9107249)

  • 1. Antithrombotic and antifibrinolytic effects of antithrombin III replacement in liver cirrhosis.
    Carmassi F; De Negri F; Morale M; Ferrini L
    Lancet; 1997 Apr; 349(9058):1069. PubMed ID: 9107249
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin III transfusion in patients with hepatic cirrhosis.
    Schipper HG; ten Cate JW
    Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in orthotopic liver transplantation: role of the recipient's disease and use of antithrombin III concentrates. S. Orsola Working Group on Liver Transplantation.
    Palareti G; Legnani C; Maccaferri M; Gozzetti G; Mazziotti A; Martinelli G; Zanello M; Sama C; Coccheri S
    Haemostasis; 1991; 21(2):68-76. PubMed ID: 1959800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the values of antithrombin III and other blood coagulation indices in liver cirrhosis without ascites and in the ascitic stage].
    Doncheva N
    Vutr Boles; 1989; 28(4):96-9. PubMed ID: 2596116
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acetylcholine and atropine on the release by the intestine of hemocoagulating substances into blood].
    Golyshenkov SP; Skipetrov VP
    Fiziol Zh SSSR Im I M Sechenova; 1982 Sep; 68(9):1240-5. PubMed ID: 7173439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 9. Early treatment with AT III in acute liver failure.
    Vogel GE
    Behring Inst Mitt; 1983 Aug; (73):79-93. PubMed ID: 6679286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III metabolism in patients with liver disease.
    Knot E; Ten Cate JW; Drijfhout HR; Kahlé LH; Tytgat GN
    J Clin Pathol; 1984 May; 37(5):523-30. PubMed ID: 6725600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin III].
    Lagutina NIa; Fedulova GA
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):42-50. PubMed ID: 7045862
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation in cirrhosis patients: what don't we know?
    Northup PG; Intagliata NM
    Liver Int; 2011 Jan; 31(1):4-6. PubMed ID: 21092072
    [No Abstract]   [Full Text] [Related]  

  • 14. The significance of low antithrombin III levels in cirrhosis.
    Dumitraşcu DL; Radu D; Vonica A
    Rom J Intern Med; 1991; 29(3-4):151-4. PubMed ID: 1784943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
    Gotoh K
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):571-80. PubMed ID: 3989338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of AT-III concentrate during liver transplantation.
    Christophe JL; Rouget C; Roullier M; Guyot F; Kieffer Y; Costes Y; Bresson S; Mantion G; Gillet M; Barale F
    Transplant Proc; 1991 Jun; 23(3):1942-3. PubMed ID: 2063435
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.
    Lisman T; Leebeek FW; Meijer K; Van Der Meer J; Nieuwenhuis HK; De Groot PG
    Hepatology; 2002 Mar; 35(3):616-21. PubMed ID: 11870375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.